PANACEABIONSEPanacea Biotec Limited· PharmaceuticalsMediumNeutral
Announced Wed, 1 Apr · 10:07 IST

Panacea Biotec Limited has informed the Exchange regarding Cessation of Mr Mukul Gupta (DIN: 00254597) as Non- Executive Independent Director of the company w.e.f. March 31, 2026.

Kmp ResignedDirector Flagged GovernanceManagement Changes View source PDF

PANACEABIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+8.3%1-day move
₹297.40
prior close
₹319.45
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.3+0.1+1.8+8.3+8.3+7.6+11.9+8.6+11.8+24.7+25.8+33.9+82.6
Up moveDown movePending
AI summary

Panacea Biotec Limited has announced that Mr. Mukul Gupta has ceased to be an Independent Director of the company effective March 31, 2026. He completed his second and final term of 5 consecutive years as Independent Director on that date. Following this, he has also ceased to be the Chairperson and member of all Committees of the Board of Directors. The Board expressed appreciation for his extensive contribution and guidance towards the company's business growth during his tenure.

Likely market impact

This is a routine governance change as Mr. Gupta's tenure ended naturally upon completion of his maximum permitted term of 10 years as an Independent Director under SEBI regulations. Shareholders should note the company will need to appoint a new Independent Director to maintain board composition requirements.